VIVUS Receives Notification of Qnexa(R) PDUFA Date Extension | bestweightlossguide.com

VIVUS Receives Notification of Qnexa(R) PDUFA Date Extension

Dietary Approach to Stop Hypertension 09.04.2012
MOUNTAIN VIEW, Calif., Apr 9, 2012 (GlobeNewswire via COMTEX) — The US Food and Drug Administration (FDA) informed VIVUS (NASDAQ:VVUS) of an extended Prescription Drug User Fee Act (PDUFA) date for its review of the Qnexa New Drug Application (NDA) …
See all stories on this topic »

Related Blogs
Be Sociable, Share!
We LOVE you so.. how about liking us on Facebook?..

Powered By Facebook Like Post Plugin
Posted by MarketWatch (press release) @ 5:44 pm

Tags: Act, Drug Application, Fda, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Mountain View, Nasdaq, Pdufa Date, Prescription Drug, Qnexa, Us Food And Drug Administration, Vivus, Vvus
Leave a Reply Cancel reply
Your email address will not be published. Required fields are marked *
Comment
Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

CAPTCHA Code *

Click to cancel reply

Contest (1)
Dietary Approach to Stop Hypertension (11,004)
DVD Training Review (1)
Fat Burn (138)
Fitness Home Business (2)
Free Trial (5)
Gain Energy (13)
Lose Weight (99)
Mini Workouts (226)
Weight Loss (526)
Weight Loss Mindset (4)
Workout Equipment Review (1)
Workout Music (4)

Sorry. No data so far.